Crossmark

Clinical and radiological activity after extended interval and standard interval dosing of ocrelizumab in multiple sclerosis: A systematic review and meta-analysis

Crossref DOI link: https://doi.org/10.1007/s10072-025-08098-7

Published Online: 2025-04-04

Published Print: 2025-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ghajarzadeh, Mahsa

Rastkar, Mohsen

Mowry, Ellen M

Nourbakhsh, Bardia https://orcid.org/0000-0002-6617-2003
License Information

Text and Data Mining valid from 2025-04-04

Version of Record valid from 2025-04-04
More Information

Article History

Received: 9 January 2025

Accepted: 1 March 2025

First Online: 4 April 2025

Declarations

:

: Not applicable.

: Not applicable.

: Bardia Nourbakhsh and Ellen Mowry received research funding from Genentech, unrelated to this work.

Document is current

Any future updates will be listed below